Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
31.37
-1.47 (-4.48%)
Mar 31, 2025, 10:03 AM EDT - Market open
Scholar Rock Holding Employees
Scholar Rock Holding had 128 employees as of December 31, 2024. The number of employees decreased by 22 or -14.67% compared to the previous year.
Employees
128
Change (1Y)
-22
Growth (1Y)
-14.67%
Revenue / Employee
n/a
Profits / Employee
-$1,924,172
Market Cap
2.97B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SRRK News
- 6 days ago - FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy - Business Wire
- 13 days ago - Scholar Rock Stock Jumps On Additional Data From Pivotal Trial Of Muscular Dystrophy Treatment - Benzinga
- 14 days ago - Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference - Business Wire
- 16 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Scholar Rock Holding Corporation (SRRK) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business Progress - Business Wire
- 4 weeks ago - Scholar Rock to Participate in Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - Business Wire